Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: response
Br J Haematol
.
2021 Aug;194(4):688-689.
doi: 10.1111/bjh.17535.
Epub 2021 May 16.
Authors
Henry Wood
1
2
,
Austin G Kulasekararaj
1
2
3
Affiliations
1
Department of Haematological Medicine, King's College Hospital-NHS Foundation Trust, London, UK.
2
King's College London, London, UK.
3
NIHR/Wellcome King's Clinical Research Facility, London, UK.
PMID:
33993471
PMCID:
PMC8239835
DOI:
10.1111/bjh.17535
No abstract available
Keywords:
COVID-19; hyperinflammatory syndrome; immunosuppressive therapy.
Publication types
Letter
Comment
MeSH terms
COVID-19*
Cytokine Release Syndrome
Humans
Lymphohistiocytosis, Hemophagocytic* / diagnosis
SARS-CoV-2